Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome

Microbiology and Immunology

Volumn 48, Issue 8, 2004, Pages 591-598

  Takigawa, Yuki ^a   Nagano Fujii, Motoko ^a   Deng, Lin ^a   Hidajat, Rachmat ^a   Tanaka, Motofumi ^a   Mizuta, Hiroyuki ^a   Hotta, Hak ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatitis C virus; Lentivirus vector; Nonstructural regions; RNA interference

Indexed keywords

LENTIVIRUS VECTOR; SMALL INTERFERING RNA;

5' UNTRANSLATED REGION; ARTICLE; DOSE RESPONSE; GENE SILENCING; HEPATITIS C VIRUS; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; JAPAN; NONHUMAN; PLASMID; REPLICON; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA DEGRADATION; RNA INTERFERENCE; VIRUS GENOME; VIRUS ISOLATION;

HEPATITIS C VIRUS; LENTIVIRUS; RNA VIRUSES;

EID: 4143088066     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2004.tb03556.x     Document Type: Article

References (53)

1. Amin, A., Zaccardi, J., Mullen, S., Olland, S., Orlowski, M., Feld, B., Labonte, P., and Mak, P. 2003. Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase. Virology 313: 158-169.
2. Bernstein, E., Caudy, A.A., Hammond, S.M., and Hannon, G.J. 2001. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409: 363-366.
3. Brummelkamp, T.R., Bernards, R., and Agami, R. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553.
4. Carroll, S.S., Tomassini, J.E., Bosserman, M., Getty, K., Stahlhut, M.W., Eldrup, A.B., Bhat, B., Hall, D., Simcoe, A.L., LaFemina, R., Rutkowski, C.A., Wolanski, B., Yang, Z., Migliaccio, G., De Francesco, R., Kuo, L.C., MacCoss, M., and Olsen, D.B. 2003. Inhibition of hepatitis C virus RNA replication by 2′-modified nucleoside analogs. J. Biol. Chem. 278: 11979-11984.
5. Choo, Q.-L., Richman, K.H., Han, J.H., Berger, K., Lee, C., Dong, C., Gallegos, C., Coit, D., Medina-Selby, A., Barr, P.J., Weiner, A.J., Bradley, D.W., Kuo, G., and Houghton, M. 1991. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 88: 2451-2455.
6. Coburn, G.A., and Cullen, B.R. 2002. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J. Virol. 76: 9225-9231.
7. Davis, G.L., Esteban-Mur, R., Rustgi, V., Hoefs, J., Gordon, S.C., Trepo, C., Shiffman, M.L., Zeuzem, S., Craxi, A., Ling, M.-H., and Albrecht, J. 1998. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N. Engl. J. Med. 339: 1493-1499.
8. Dhanak, D., Duffy, K.J., Johnston, V.K., Lin-Goerke, J., Darcy, M., Shaw, A.N., Gu, B., Silverman, C., Gates, A.T., Nonnemacher, M.R., Earnshaw, D.L., Casper, D.J., Kaura, A., Baker, A., Greenwood, C., Gutshall, L.L., Maley, D., DelVecchio, A., Macarron, R., Hofmann, G.A., Alnoah, Z., Cheng, H.-Y., Chan, G., Khandekar, S., Keenan, R.M., and Sarisky, R.T. 2002. Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymerase. J. Biol. Chem. 277: 38322-38327.
9. Dull, T., Zufferey, R., Kelly, M., Mandel, R.J., Nguyen, M., Trono, D., and Naldini, L. 1998. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72: 8463-8471.
10. Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498.
11. Elbashir, S.M., Lendeckel, W., and Tuschl, T. 2001. RNA interference is mediated by 21 and 22-nucleotide RNAs. Genes Dev. 15: 188-200.
12. Elbashir, S.M., Martinez, J., Patkaniowska, A., Lendeckel, W., and Tuschl, T. 2001. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20: 6877-6888.
13. Gitlin, L., Karelsky, S., and Andino, R. 2002. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418: 430-434.
14. Glue, P., Rouzier-Panis, R., Raffanel, C., Sabo, R., Gupta, S.K., Salfi, M., Jacobs, S., Clement, R.P., and The Hepatitis C Intervention Therapy Group. 2000. A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. Hepatology 32: 647-653.
15. Guo, J.-T., Bichko, V.V., and Seeger, C. 2001. Effect of alpha interferon on the hepatitis C virus replicon. J. Virol. 75: 8516-8523.
16. Hamilton, A.J., and Baulcombe, D.C. 1999. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 286: 950-952.
17. Jacque, J.-M., Triques, K., and Stevenson, M. 2002. Modulation of HIV-1 replication by RNA interference. Nature 418: 435-438.
18. Kafri, T., Blomer, U., Peterson, D.A., Gage, F.H., and Verma, I.M. 1997. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17: 314-317.
19. Kapadia, S.B., Brideau-Andersen, A., and Chisari, F.V. 2003. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc. Natl. Acad. Sci. U.S.A. 100: 2014-2018.
20. Kim, J.L., Morgenstern, K.A., Lin, C., Fox, T., Dwyer, M.D., Landro, J.A., Chambers, S.P., Markland, W., Lepre, C.A., O'Malley, E.T., Harbeson, S.L., Rice, C.M., Murcko, M.A., Caron, P.R., and Thomson, J.A. 1996. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 87: 343-355.
21. Kiyosawa, K., Sodeyama, T., Tanaka, E., Gibo, Y., Yoshizawa, K., Nakano, Y., Furuta, S., Akahane, Y., Nishioka, K., Purcell, R.H., and Alter, H.J. 1990. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12: 671-675.
22. Lee, N.S., Dohjima, T., Bauer, G., Li, H., Li, M.-J., Ehsani, A., Salvaterra, P., and Rossi, J. 2002. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20: 500-505.
23. Lewis, D.L., Hagstrom, J.E., Loomis, A.G., Wolff, J.A., and Herweijer, H. 2002. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat. Genet. 32: 107-108.
24. Li, H., Li, W.X., and Ding, S.W. 2002. Induction and suppression of RNA silencing by an animal virus. Science 296: 1319-1321.
25. Lindsay, K.L., Trepo, C., Heintges, T., Shiffman, M.L., Gordon, S.C., Hoefs, J.C., Schiff, E.R., Goodman, Z.D., Laughlin, M., Yao, R., and Albrecht, J.K. 2001. A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C. Hepatology 34: 395-403.
26. Lohmann, V., Kömer, F., Dobierzewska, A., and Bartenschlager, R. 2001. Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J. Virol. 75: 1437-1449.
27. Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., and Bartenschlager, R. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285: 110-113.
28. Love, R.A., Parge, H.E., Wickersham, J.A., Hostomsky, Z., Habuka, N., Moomaw, E.W., Adachi, T., and Hostomska, Z. 1996. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell 87: 331-342.
29. McCaffrey, A.P., Meuse, L., Pham, T.-T.T., Conklin, D.S., Hannon, G.J., and Kay, M.A. 2002. RNA interference in adult mice. Nature 418: 38-39.
30. McHutchison, J.G., Gordon, S.C., Schiff, E.R., Shiffman, M.L., Lee, W.M., Rustgi, V.K., Goodman, Z.D., Ling, M.-H., Cort, S., and Albrecht, J.K. 1998. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N. Engl. J. Med. 339: 1485-1492.
31. Miller, V.M., Gouvion, C.M., Davidson, B.L., and Paulson, H.L. 2004. Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles. Nucleic Acids Res. 32: 661-668.
32. Miyagishi, M., and Taira, K. 2002. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol. 20: 497-500.
33. Ogata, S., Florese, R.H., Nagano-Fujii, M., Hidajat, R., Deng, L., Ku, Y., Yoon, S., Saito, T., Kawata, S., and Hotta, H. 2003. Identification of hepatitis C virus (HCV) subtype lb strains that are highly, or only weakly, associated with hepatocellular carcinoma on the basis of secondary structure of an amino-terminal portion of the HCV NS3 protein. J. Clin. Microbiol. 41: 2835-2841.
34. Ogata, S., Ku, Y., Yoon, S., Makino, S., Nagano-Fujii, M., and Hotta, H. 2002. Correlation between secondary structure of an amino-terminal portion of the nonstructural protein 3 (NS3) of hepatitis C virus and development of hepatocellular carcinoma. Microbiol. Immunol. 46: 549-554.
35. Ogata, S., Nagano-Fujii, M., Ku, Y., Yoon, S., and Hotta, H. 2002. Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma. J. Clin. Microbiol. 40: 3625-3630.
36. Oka, K., Nagano-Fujii, M., Yoshida, I., Hidajat, R., Deng, L., Akutsu, M., and Hotta, H. 2003. Hepatitis C virus core protein selectively inhibits synthesis and accumulation of p21/Waf1 and certain nuclear proteins. Microbiol. Immunol. 47: 429-438.
37. Paddison, P.J., Caudy, A.A., Bernstein, E., Hannon, G.J., and Conklin, D.S. 2002. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16: 948-958.
38. Paul, C.P., Good, P.D., Winer, I., and Engelke, D.R. 2002. Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20: 505-508.
39. Pause, A., Kukolj, G., Bailey, M., Brault, M., Dô, F., Halmos, T., Lagacé, L., Maurice, R., Marquis, M., McKercher, G., Pellerin, C., Pilote, L., Thibeault, D., and Lamarre, D. 2003. An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA. J. Biol. Chem. 278: 20374-20380.
40. Randall, G., Grakoui, A., and Rice, C.M. 2003. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc. Natl. Acad. Sci. U.S.A. 100: 235-240.
41. Reddy, K.R., Wright, T.L., Pockros, P.J., Shiffman, M., Everson, G., Reindollar, R., Fried, M.W., Purdum, P.P., 3rd, Jensen, D., Smith, C., Lee, W.M., Boyer, T.D., Lin, A., Pedder, S., and DePamphilis, J. 2001. Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C. Hepatology 33: 433-438.
42. Rubinson, D.A., Dillon, C.P., Kwiatkowski, A.V., Sievers, C., Yang, L., Kopinja, J., Zhang, M., McManus, M.T., Gertler, F.B., Scott, M.L., and Van Parijs, L. 2003. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33: 401-406.
43. Scherr, M., Battmer, K., Winkler, T., Heidenreich, O., Ganser, A., and Eder, M. 2003. Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood 101: 1566-1569.
44. Seo, M.Y., Abrignani, S., Houghton, M., and Han, J.H. 2003. Small interfering RNA-mediated inhibition of hepatitis C virus replication in the human hepatoma cell line Huh-7. J. Virol. 77: 810-812.
45. Sui, G., Soohoo, C., Affar, E.B., Gay, F., Shi, Y., Forrester, W.C., and Shi, Y. 2002. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 99: 5515-5520.
46. Tong, M.J., El-Farra, N.S., Reikes, A.R., and Co, R.L. 1995. Clinical outcomes after transfusion-associated hepatitis C. N. Engl. J. Med. 332: 1463-1466.
47. VandenDriessche, T., Thorrez, L., Naldini, L., Follenzi, A., Moons, L., Berneman, Z., Collen, D., and Chuah, M.K.L. 2002. Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo. Blood 100: 813-822.
48. Varambally, S., Dhanasekaran, S.M., Zhou, M., Barrette, T.R., Kumar-Sinha, C., Sanda, M.G., Ghosh, D., Pienta, K.J., Sewalt, R.G.A.B., Otte, A.P., Rubin, M.A., and Chinnaiyan, A.M. 2002. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419: 624-629.
49. Wilson, J.A., Jayasena, S., Khvorova, A., Sabatinos, S., Rodrigue-Gervais, I.G., Arya, S., Sarangi, F., Harris-Brandts, M., Beaulieu, S., and Richardson, C.D. 2003. RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc. Natl. Acad. Sci. U.S.A. 100: 2783-2788.
50. Xia, H., Mao, Q., Paulson, H.L., and Davidson, B.L. 2002. siRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol. 20: 1006-1010.
51. Yokota, T., Sakamoto, N., Enomoto, N., Tanabe, Y., Miyagishi, M., Maekawa, S., Yi, L., Kurosaki, M., Taira, K., Watanabe, M., and Mizusawa, H. 2003. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep. 4: 602-608.
52. Yu, J.-Y., DeRuiter, S.L., and Turner, D.L. 2002. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 99: 6047-6052.
53. Zamore, P.D., Tuschl, T., Sharp, P.A., and Bartel, D.P. 2000. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101: 25-33.